These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1411 related items for PubMed ID: 18025532

  • 1. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, Mahaffey KW.
    Circulation; 2007 Dec 04; 116(23):2669-77. PubMed ID: 18025532
    [Abstract] [Full Text] [Related]

  • 2. Evaluating the optimal timing of angiography: landmark or off the mark?
    Normand SL.
    Circulation; 2007 Dec 04; 116(23):2656-7. PubMed ID: 18056535
    [No Abstract] [Full Text] [Related]

  • 3. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
    Mehta SR, Boden WE, Eikelboom JW, Flather M, Steg PG, Avezum A, Afzal R, Piegas LS, Faxon DP, Widimsky P, Budaj A, Chrolavicius S, Rupprecht HJ, Jolly S, Granger CB, Fox KA, Bassand JP, Yusuf S, OASIS 5 and 6 Investigators.
    Circulation; 2008 Nov 11; 118(20):2038-46. PubMed ID: 18955665
    [Abstract] [Full Text] [Related]

  • 4. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, Manoukian SV, Feit F, Ohman ME, Witzenbichler B, Guagliumi G, Lansky AJ, Stone GW.
    J Am Coll Cardiol; 2010 Jun 08; 55(23):2556-66. PubMed ID: 20513595
    [Abstract] [Full Text] [Related]

  • 5. Exploring the role of enoxaparin in the management of high-risk patients with non-ST-elevation acute coronary syndromes: the SYNERGY trial.
    Mahaffey KW, Ferguson JJ.
    Am Heart J; 2005 Apr 08; 149(4 Suppl):S81-90. PubMed ID: 16124952
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
    White HD, Kleiman NS, Mahaffey KW, Lokhnygina Y, Pieper KS, Chiswell K, Cohen M, Harrington RA, Chew DP, Petersen JL, Berdan LG, Aylward PE, Nessel CC, Ferguson JJ, Califf RM.
    Am Heart J; 2006 Dec 08; 152(6):1042-50. PubMed ID: 17161049
    [Abstract] [Full Text] [Related]

  • 7. Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Mahaffey KW, Tonev ST, Spinler SA, Levine GN, Gallo R, Ducas J, Goodman SG, Antman EM, Becker RC, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM, SYNERGY Trial Investigators.
    Int J Cardiol; 2010 Mar 04; 139(2):123-33. PubMed ID: 19012977
    [Abstract] [Full Text] [Related]

  • 8. Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes.
    Dabbous OH, Anderson FA, Gore JM, Eagle KA, Fox KA, Mehta RH, Goldberg RJ, Agnelli G, Steg PG, GRACE Investigators.
    Heart; 2008 Feb 04; 94(2):159-65. PubMed ID: 17575335
    [Abstract] [Full Text] [Related]

  • 9. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
    Chew DP, Huang Z, Pieper KS, White H, Mahaffey KW, Ferguson JJ, Califf RM, Aylward PG.
    Am Heart J; 2008 Feb 04; 155(2):239-44. PubMed ID: 18215592
    [Abstract] [Full Text] [Related]

  • 10. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
    Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, Montalescot G, Granger CB, Knobel E, Anderson FA, Dabbous OH, Avezum A, GRACE Investigators.
    Arch Intern Med; 2009 Feb 23; 169(4):402-9. PubMed ID: 19237725
    [Abstract] [Full Text] [Related]

  • 11. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, Demopoulos LA, DiBattiste PM, Weintraub WS, McCabe CH, Antman EM, Cannon CP, Braunwald E.
    Circulation; 2004 Feb 24; 109(7):874-80. PubMed ID: 14757697
    [Abstract] [Full Text] [Related]

  • 12. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ, Hendel RC, Nathan S, Meyer PM, Calvin JE, Klein LW.
    J Invasive Cardiol; 2003 Sep 24; 15(9):502-6. PubMed ID: 12947210
    [Abstract] [Full Text] [Related]

  • 13. Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.
    Leung S, Gallup D, Mahaffey KW, Cohen M, Antman EM, Goodman SG, Harrington RA, Langer A, Aylward P, Ferguson JJ, Califf RM, SYNERGY Trial Investigators.
    Am Heart J; 2008 Jul 24; 156(1):177-84. PubMed ID: 18585514
    [Abstract] [Full Text] [Related]

  • 14. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland.
    Poloński L, Gasior M, Gierlotka M, Kalarus Z, Cieśliński A, Dubiel JS, Gil RJ, Ruzyłło W, Trusz-Gluza M, Zembala M, Opolski G.
    Kardiol Pol; 2007 Aug 24; 65(8):861-72; discussion 873-4. PubMed ID: 17853315
    [Abstract] [Full Text] [Related]

  • 15. Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
    Lopes RD, Alexander KP, Marcucci G, White HD, Spinler S, Col J, Aylward PE, Califf RM, Mahaffey KW.
    Eur Heart J; 2008 Aug 24; 29(15):1827-33. PubMed ID: 18519426
    [Abstract] [Full Text] [Related]

  • 16. Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.
    Hirsch A, Windhausen F, Tijssen JG, Oude Ophuis AJ, van der Giessen WJ, van der Zee PM, Cornel JH, Verheugt FW, de Winter RJ, Invasive versus Conservative Treatment in Unstable coronary Syndromes Investigators.
    Eur Heart J; 2009 Mar 24; 30(6):645-54. PubMed ID: 18824461
    [Abstract] [Full Text] [Related]

  • 17. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
    Gibson CM, Murphy SA, Montalescot G, Morrow DA, Ardissino D, Cohen M, Gulba DC, Kracoff OH, Lewis BS, Roguin N, Antman EM, Braunwald E, ExTRACT-TIMI 25 Investigators.
    J Am Coll Cardiol; 2007 Jun 12; 49(23):2238-46. PubMed ID: 17560287
    [Abstract] [Full Text] [Related]

  • 18. Disparities in management patterns and outcomes of patients with non-ST-elevation acute coronary syndrome with and without a history of cerebrovascular disease.
    Lee TC, Goodman SG, Yan RT, Grondin FR, Welsh RC, Rose B, Gyenes G, Zimmerman RH, Brossoit R, Saposnik G, Graham JJ, Yan AT, Canadian Acute Coronary Syndromes I and II, Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) and the Canadian Registry of Acute Coronary Events (CANRACE) Investigators.
    Am J Cardiol; 2010 Apr 15; 105(8):1083-9. PubMed ID: 20381657
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.
    Rao SV, O'Grady K, Pieper KS, Granger CB, Newby LK, Mahaffey KW, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Harrington RA.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):809-16. PubMed ID: 16487850
    [Abstract] [Full Text] [Related]

  • 20. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
    Kaul P, Armstrong PW, Chang WC, Naylor CD, Granger CB, Lee KL, Peterson ED, Califf RM, Topol EJ, Mark DB.
    Circulation; 2004 Sep 28; 110(13):1754-60. PubMed ID: 15381645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.